February 13, 2026

Diacerein shows promise as disease-modifying therapy in rheumatoid arthritis – News-Medical

February 12, 2026

Early-Life Animal Exposure May Modify Future Rheumatoid Arthritis Risk, suggests study – Medical Dialogues

February 7, 2026

Lupin and Yoshindo’s JV – YL Biologics announces successful outcome of global Phase III study for Etanercept biosimilar in Rheumatoid Arthritis – Lupin | Press Release – lupin.com

February 5, 2026

Rheumatoid Arthritis Resource Center – Everyday Health

January 28, 2026

Rewriting the future of rheumatoid arthritis: How early detection is transforming prevention – Mayo Clinic News Network